Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Avelumab With Binimetinib, Sacituzumab Govitecan, or Liposomal Doxorubicin in Treating Stage IV or Unresectable, Recurrent Triple Negative Breast Cancer

Laura Huppert, MD, BA · 2019
ClinicalTrials.gov · Datasets · License: Public Domain · 2019
Open Source ↗
stage iii breast cancer, stage iiia breast cancer, stage iiib breast cancer, stage iiic breast cancer, stage iv breast cancer, invasive breast carcinoma, recurrent breast carcinoma, triple-negative breast carcinoma, unresectable breast carcinoma, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 860236
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.